申请人:F. Hoffmann-La Roche AG
公开号:EP2351737A1
公开(公告)日:2011-08-03
The present invention provides compounds of the formula:
or pharmaceutically acceptable salts, solvates or prodrugs thereof,
wherein p, Ar, R1, R2, R3, Ra Rb, Rc, Rd and Re are defined herein. Also provided are pharmaceutical compositions, methods of using, and methods of preparing the compounds
本发明提供了式中化合物:
或其药学上可接受的盐、溶液或原药、
其中 p、Ar、R1、R2、R3、Ra Rb、Rc、Rd 和 Re 在本文中定义。此外,还提供了这些化合物的药物组合物、使用方法和制备方法